Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis

Journal of Interferon and Cytokine Research

Volumn 30, Issue 9, 2010, Pages 653-660

  Wen, Xiangshu ^a,d   Kudo, Tomoya ^b,c   Payne, Laura ^a   Wang, Xisheng ^a,d   Rodgers, Laurel ^a,e   Suzuki, Yasuhiro ^a,b  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; WILD TYPE;

ANIMALS; BRAIN; CHEMOKINE CCL5; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHRONIC DISEASE; ENCEPHALITIS; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RNA, MESSENGER; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALIA; MUS; TOXOPLASMA GONDII;

EID: 77956583188     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0119     Document Type: Article

References (35)

1. Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti D, Pelloux H, Marty P, Darde ML. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 186:684-689.
2. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
3. Barnes DA, Huston M, Holmes R, Benveniste EN, Yong VW, Scholz P, Perez HD. 1996. Induction of RANTES expression by astro-cytes and astrocytoma cell lines. J Neuroimmunol 71:207-214.
4. Brown CR, Hunter CA, Estes RG, Beckmann E, Forman J, David C, Remington JS, McLeod R. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-428.
5. Chao CC, Anderson WR, Hu S, Gekker G, Martella A, Peterson PK. 1993. Activated microglia inhibit multiplication of Tox-oplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol 67:178-183.
6. Couper KN, Lanthier PA, Perona-Wright G, Kummer LW, Chen W, Smiley ST, Mohrs M, Johnson LL. 2009. Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Tox-oplasma gondii infection. J Immunol 182:3985-3994.
7. Croitoru-Lamoury J, Guillemin GL, Boussin FD, Mognetti B, Gigout LI, Cheret A, Vaslin B, Le Grand R, Brew BJ, Dormont D. 2003. Expression of chemokine and their receptors in human simian astrocytes: evidence for a central role of TNF-a and IFN-g in CXCR4 and CCR5 modulation. Glia 41:354-370.
8. Denkers EY, Gazzinelli RT. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11:569-588.
9. Farber JM. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61:246-257.
10. Fine JS, Rojas-Triana A, Jackson JV, Engstrom LW, Deno GS, Lundell DJ, Bober LA. 2003. Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10. Inflammation 27:161-174.
11. Halonen SK, Taylor GA, Weiss LM. 2001. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun 69:5573-5576.
12. Hamilton NH, Banyer JL, Hapel AJ, Mahalingam S, Ramsay AJ, Ramshaw IA, Thomson SA. 2002. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand J Immunol 55:171-177.
13. Honore S, Couvelard A, Garin YJ, Bedel C, Henin D, Darde ML, Derouin F. 2000. [Genotyping of Toxoplasma gondii strains from immunocompromised patients]. Pathol Biol (Paris) 48:541-547.
14. Howe DK, Honore S, Derouin F, Sibley LD. 1997. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 35:1411-1414.
15. Israelski DM, Remington JS. 1993. Toxoplasmosis in the non-AIDS immunocompromised host. Curr Clin Top Infect Dis 13:322-356.
16. Kang H, Liesenfeld O, Remington JS, Claflin J, Wang X, Suzuki Y. 2003. TCR V beta 8\+ T cells prevent development of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. J Immunol 170:4254-4259.
17. Kang H, Suzuki Y. 2001. Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect Immun 69:2920-2927.
18. Khan IA, Maclean JA, Lee FS, Casciotti L, Dehaan E, Schwartzman JD, Luster AD. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12:483-494.
19. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C, Schwartzman JD, Luster AD. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2:e49.
20. Komatsu K, Miyazaki D, Morohoshi K, Kuo CH, Kakimaru-Hasegawa A, Komatsu N, Namba S, Haino M, Matsushima K, Inoue Y. 2008. Pathogenesis of herpetic stromal keratitis in CCR-5-and/or CXCR3-deficient mice. Curr Eye Res 33:736-749.
21. Liu MT, Armstrong D, Hamilton TA, Lane TE. 2001. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 166:1790-1795.
22. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165:2327-2330.
23. Moser B, Loetscher P. 2001. Lymphocyte traffic control by che-mokines. Nat Immunol 2:123-128.
24. Salmaggi A, Geliati M, Dufour A, Corsini E, Pagano S, Baccalini R, Ferrero E, Scabini S, Silei V, Ciusani E, De Rossi M. 2002. Expression and modulation of IFN-g-inducible chemokines (IP-10, MIG, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J Interferon Cytokine Res 22:631-640.
25. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 157:4045-4054.
26. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185:1261-1273.
27. Strack A, Asensio VC, Campbell IL, Schluter D, Deckert M. 2002. Chemokines are differentially expressed by astrocytes, mi-croglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol (Berl) 103:458-468.
28. Suzuki Y, Claflin J, Wang X, Lengi A, Kikuchi T. 2005. Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii. Int J Parasitol 35:83-90.
29. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
30. Suzuki Y, Orellana MA, Wong SY, Conley FK, Remington JS. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlated with susceptibility to acute infection in mice. Infect Immun 61:2284-2288.
31. Ure DR, Lane TE, Liu MT, Rodriguez M. 2005. Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int Immunol 17:569-579.
32. Wang X, Claflin J, Kang H, Suzuki Y. 2005. Importance of CD8(\+)Vbeta8(\+) T Cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice. J Interferon Cytokine Res 25:338-344.
33. Wang X, Kang H, Kikuchi T, Suzuki Y. 2004. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infect Immun 72:4432-4438.
34. \+ T cells into the brain during chronic infection with Toxoplasma gondii. J Interferon Cytokine Res 27:329-338.
35. Wong SY, Remington JS. 1994. Toxoplasmosis in the setting of AIDS. In: Broder S, Mergan TC, Jr., Bolognesi D, eds. Text book of AIDS medicine. Baltimore: Williams & Wikins, pp 223-257.